_id
6910550fccc777a4e85d55ac
Ticker
CRRTF
Name
Crescita Therapeutics Inc
Exchange
PINK
Address
2805, Place Louis R Renaud, Laval, QC, Canada, H7V 0A3
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.crescitatherapeutics.com
Description
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud and Aquafolia brands; and medical aesthetics under the Pro-Derm and Alyria brands for non-invasive and minimally invasive procedures or skincare treatments. The company also distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; ART FILLER, a hyaluronic acid-based dermal filler; and MicronJet, an intradermal injection device. The company has commercialization license agreement with Cantabria Labs Inc.; and development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
Last Close
0.3439
Volume
107
Current Price
0.3399
Change
0.0078
Last Updated
2026-01-02T12:00:50.987Z
Image
data:image/webp;base64,UklGRloBAABXRUJQVlA4IE4BAADwCQCdASpAAEAAPrVUo0wnJKMiKBv6qOAWiWQ7fnQAhSmy2C6PRIIUe2W/jHQ3PEAAVyjmW1uoGb851SmlLNb0QfX0TWmSoUYIxPKSakcFJMl0du/BJMbsAP7WDJy6Dklm9+CEh7+91ke2ZcMql6puhEpZCP8N8eJ5olE7DgJ54n3AJ2ws13n8E5VmUo8m0xntHeK0DWZuG4u5VwBOfRD4dPGYs/aHQNP6KbNJkuRLO5MPxYdtUfUw1c6PQr8BBYCcr6IiQ3R0sdZD9vVnW9GCjZp2P1f+TMTgVnC9pitwJTDWSYYBzGHYm/FGUaAnp0gRyC+Eiz1Ql7n0NMeXiPYjBySzfASMLgfUAG6O/KaawHMADmMaYWZEAmzwuK3IY49g8MB9kArUBvXo0O75MnHGv9/cg3IpQI/LYeszMORCxyXhrxSH219MjKoUGrgA
Ipo Date
-
Market Cap
6401147
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
5393000
Cost Of Revenue
2538000
Gross Profit
2855000
Operating Expenses
3017000
Operating Income
-162000
Interest Expense
10000
Pretax Income
753000
Net Income
753000
Eps
0.03994936351857017
Dividends Per Share
-
Shares Outstanding
18613938
Income Tax Expense
-
EBITDA
1147000
Operating Margin
-3.0038939365844612
Total Other Income Expense Net
915000
Cash
8308000
Short Term Investments
-
Receivables
1911000
Inventories
5363000
Total Current Assets
15985000
Property Plant Equipment
2122000
Total Assets
21456000
Payables
-
Short Term Debt
484000
Long Term Debt
-
Total Liabilities
5200000
Equity
16256000
Bs_currency_symbol
CAD
Depreciation
384000
Change In Working Capital
706000
Cash From Operations
1173000
Capital Expenditures
46000
Cash From Investing
-821000
Cash From Financing
-239000
Net Change In Cash
124000
Cf_currency_symbol
CAD
PE
34.389
PB
0.39411465636687987
ROE
4.632135826771654
ROA
3.509507829977629
FCF
1127000
Fcf Percent
0.20897459669942517
Piotroski FScore
4
Health Score
75
Deep Value Investing Score
9
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
7.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
4.5
Net Net Investing Score
8.5
Quality Investing Score
5.5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
5393000
Quarters > 0 > income Statement > cost Of Revenue
2538000
Quarters > 0 > income Statement > gross Profit
2855000
Quarters > 0 > income Statement > operating Expenses
3017000
Quarters > 0 > income Statement > operating Income
-162000
Quarters > 0 > income Statement > interest Expense
10000
Quarters > 0 > income Statement > pretax Income
753000
Quarters > 0 > income Statement > net Income
753000
Quarters > 0 > income Statement > eps
0.03994936351857017
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18848861
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
1147000
Quarters > 0 > income Statement > operating Margin
-3.0038939365844612
Quarters > 0 > income Statement > total Other Income Expense Net
915000
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
8308000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1911000
Quarters > 0 > balance Sheet > inventories
5363000
Quarters > 0 > balance Sheet > total Current Assets
15985000
Quarters > 0 > balance Sheet > property Plant Equipment
2122000
Quarters > 0 > balance Sheet > total Assets
21456000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
484000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5200000
Quarters > 0 > balance Sheet > equity
16256000
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
753000
Quarters > 0 > cash Flow > depreciation
384000
Quarters > 0 > cash Flow > change In Working Capital
706000
Quarters > 0 > cash Flow > cash From Operations
1173000
Quarters > 0 > cash Flow > capital Expenditures
46000
Quarters > 0 > cash Flow > cash From Investing
-821000
Quarters > 0 > cash Flow > cash From Financing
-239000
Quarters > 0 > cash Flow > net Change In Cash
124000
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
0.03994936351857017
Quarters > 0 > ratios > PB
0.39411465636687987
Quarters > 0 > ratios > ROE
4.632135826771654
Quarters > 0 > ratios > ROA
3.509507829977629
Quarters > 0 > ratios > FCF
1127000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.20897459669942517
Quarters > 0 > health Score
75
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
6233000
Quarters > 1 > income Statement > cost Of Revenue
2408000
Quarters > 1 > income Statement > gross Profit
3825000
Quarters > 1 > income Statement > operating Expenses
3242000
Quarters > 1 > income Statement > operating Income
583000
Quarters > 1 > income Statement > interest Expense
12000
Quarters > 1 > income Statement > pretax Income
798000
Quarters > 1 > income Statement > net Income
798000
Quarters > 1 > income Statement > eps
0.04191899925585897
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
19036714
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
1163000
Quarters > 1 > income Statement > operating Margin
9.353441360500561
Quarters > 1 > income Statement > total Other Income Expense Net
215000
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
8184000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2267000
Quarters > 1 > balance Sheet > inventories
4932000
Quarters > 1 > balance Sheet > total Current Assets
15777000
Quarters > 1 > balance Sheet > property Plant Equipment
2302000
Quarters > 1 > balance Sheet > total Assets
21886000
Quarters > 1 > balance Sheet > payables
5547000
Quarters > 1 > balance Sheet > short Term Debt
479000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6274000
Quarters > 1 > balance Sheet > equity
15612000
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
798000
Quarters > 1 > cash Flow > depreciation
353000
Quarters > 1 > cash Flow > change In Working Capital
-1052000
Quarters > 1 > cash Flow > cash From Operations
-3000
Quarters > 1 > cash Flow > capital Expenditures
170000
Quarters > 1 > cash Flow > cash From Investing
-170000
Quarters > 1 > cash Flow > cash From Financing
-175000
Quarters > 1 > cash Flow > net Change In Cash
-354000
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
0.04191899925585897
Quarters > 1 > ratios > PB
0.41446189396617983
Quarters > 1 > ratios > ROE
5.111452728670254
Quarters > 1 > ratios > ROA
3.646166499131865
Quarters > 1 > ratios > FCF
-173000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.02775549494625381
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3537000
Quarters > 2 > income Statement > cost Of Revenue
1790000
Quarters > 2 > income Statement > gross Profit
1747000
Quarters > 2 > income Statement > operating Expenses
2809000
Quarters > 2 > income Statement > operating Income
-1062000
Quarters > 2 > income Statement > interest Expense
12000
Quarters > 2 > income Statement > pretax Income
-932000
Quarters > 2 > income Statement > net Income
-932000
Quarters > 2 > income Statement > eps
-0.04898016671124983
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
19028110
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-567000
Quarters > 2 > income Statement > operating Margin
-30.025445292620866
Quarters > 2 > income Statement > total Other Income Expense Net
130000
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
8538000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1567000
Quarters > 2 > balance Sheet > inventories
5097000
Quarters > 2 > balance Sheet > total Current Assets
15546000
Quarters > 2 > balance Sheet > property Plant Equipment
2285000
Quarters > 2 > balance Sheet > total Assets
21756000
Quarters > 2 > balance Sheet > payables
6050000
Quarters > 2 > balance Sheet > short Term Debt
474000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6889000
Quarters > 2 > balance Sheet > equity
14867000
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-932000
Quarters > 2 > cash Flow > depreciation
353000
Quarters > 2 > cash Flow > change In Working Capital
146000
Quarters > 2 > cash Flow > cash From Operations
-513000
Quarters > 2 > cash Flow > capital Expenditures
66000
Quarters > 2 > cash Flow > cash From Investing
-66000
Quarters > 2 > cash Flow > cash From Financing
-159000
Quarters > 2 > cash Flow > net Change In Cash
-735000
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.04898016671124983
Quarters > 2 > ratios > PB
0.43503427651846366
Quarters > 2 > ratios > ROE
-6.268917737270464
Quarters > 2 > ratios > ROA
-4.283875712447141
Quarters > 2 > ratios > FCF
-579000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.1636980491942324
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6902000
Quarters > 3 > income Statement > cost Of Revenue
3907000
Quarters > 3 > income Statement > gross Profit
2995000
Quarters > 3 > income Statement > operating Expenses
3263000
Quarters > 3 > income Statement > operating Income
-268000
Quarters > 3 > income Statement > interest Expense
15000
Quarters > 3 > income Statement > pretax Income
-176000
Quarters > 3 > income Statement > net Income
-162000
Quarters > 3 > income Statement > eps
-0.008405761682646694
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
19272495
Quarters > 3 > income Statement > income Tax Expense
-14000
Quarters > 3 > income Statement > EBITDA
204000
Quarters > 3 > income Statement > operating Margin
-3.8829324833381627
Quarters > 3 > income Statement > total Other Income Expense Net
92000
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
9273000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1583000
Quarters > 3 > balance Sheet > inventories
4051000
Quarters > 3 > balance Sheet > total Current Assets
15304000
Quarters > 3 > balance Sheet > property Plant Equipment
2423000
Quarters > 3 > balance Sheet > total Assets
21776000
Quarters > 3 > balance Sheet > payables
4996000
Quarters > 3 > balance Sheet > short Term Debt
469000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5947000
Quarters > 3 > balance Sheet > equity
15829000
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-162000
Quarters > 3 > cash Flow > depreciation
365000
Quarters > 3 > cash Flow > change In Working Capital
1111000
Quarters > 3 > cash Flow > cash From Operations
1376000
Quarters > 3 > cash Flow > capital Expenditures
353000
Quarters > 3 > cash Flow > cash From Investing
-353000
Quarters > 3 > cash Flow > cash From Financing
-240000
Quarters > 3 > cash Flow > net Change In Cash
835000
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.008405761682646694
Quarters > 3 > ratios > PB
0.41384301285615005
Quarters > 3 > ratios > ROE
-1.023437993556131
Quarters > 3 > ratios > ROA
-0.7439382806759736
Quarters > 3 > ratios > FCF
1023000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.1482179078527963
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
19580000
Annuals > 0 > income Statement > cost Of Revenue
9972000
Annuals > 0 > income Statement > gross Profit
9608000
Annuals > 0 > income Statement > operating Expenses
12823000
Annuals > 0 > income Statement > operating Income
-3215000
Annuals > 0 > income Statement > interest Expense
65000
Annuals > 0 > income Statement > pretax Income
-2764000
Annuals > 0 > income Statement > net Income
-2750000
Annuals > 0 > income Statement > eps
-0.14269039893381735
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
19272495
Annuals > 0 > income Statement > income Tax Expense
-14000
Annuals > 0 > income Statement > EBITDA
-1333000
Annuals > 0 > income Statement > operating Margin
-16.419816138917263
Annuals > 0 > income Statement > total Other Income Expense Net
451000
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
9273000
Annuals > 0 > balance Sheet > short Term Investments
3000
Annuals > 0 > balance Sheet > receivables
1583000
Annuals > 0 > balance Sheet > inventories
4051000
Annuals > 0 > balance Sheet > total Current Assets
15304000
Annuals > 0 > balance Sheet > property Plant Equipment
2423000
Annuals > 0 > balance Sheet > total Assets
21776000
Annuals > 0 > balance Sheet > payables
4996000
Annuals > 0 > balance Sheet > short Term Debt
469000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5947000
Annuals > 0 > balance Sheet > equity
15829000
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-2750000
Annuals > 0 > cash Flow > depreciation
1366000
Annuals > 0 > cash Flow > change In Working Capital
3911000
Annuals > 0 > cash Flow > cash From Operations
2725000
Annuals > 0 > cash Flow > capital Expenditures
1185000
Annuals > 0 > cash Flow > cash From Investing
-2019000
Annuals > 0 > cash Flow > cash From Financing
-861000
Annuals > 0 > cash Flow > net Change In Cash
-112000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.14269039893381735
Annuals > 0 > ratios > PB
0.41871318658790824
Annuals > 0 > ratios > ROE
-17.373175816539263
Annuals > 0 > ratios > ROA
-12.628581925055107
Annuals > 0 > ratios > FCF
1540000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.07865168539325842
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
17522000
Annuals > 1 > income Statement > cost Of Revenue
7158000
Annuals > 1 > income Statement > gross Profit
10364000
Annuals > 1 > income Statement > operating Expenses
12320000
Annuals > 1 > income Statement > operating Income
-1956000
Annuals > 1 > income Statement > interest Expense
85000
Annuals > 1 > income Statement > pretax Income
-1530000
Annuals > 1 > income Statement > net Income
-1986000
Annuals > 1 > income Statement > eps
-0.09804848463006074
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
20255285
Annuals > 1 > income Statement > income Tax Expense
456000
Annuals > 1 > income Statement > EBITDA
-450000
Annuals > 1 > income Statement > operating Margin
-11.163109234105697
Annuals > 1 > income Statement > total Other Income Expense Net
426000
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
9385000
Annuals > 1 > balance Sheet > short Term Investments
3000
Annuals > 1 > balance Sheet > receivables
2775000
Annuals > 1 > balance Sheet > inventories
6125000
Annuals > 1 > balance Sheet > total Current Assets
18487000
Annuals > 1 > balance Sheet > property Plant Equipment
1846000
Annuals > 1 > balance Sheet > total Assets
24598000
Annuals > 1 > balance Sheet > payables
4325000
Annuals > 1 > balance Sheet > short Term Debt
439000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5776000
Annuals > 1 > balance Sheet > equity
18822000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-1986000
Annuals > 1 > cash Flow > depreciation
1506000
Annuals > 1 > cash Flow > change In Working Capital
1808000
Annuals > 1 > cash Flow > cash From Operations
2076000
Annuals > 1 > cash Flow > capital Expenditures
133000
Annuals > 1 > cash Flow > cash From Investing
-133000
Annuals > 1 > cash Flow > cash From Financing
-782000
Annuals > 1 > cash Flow > net Change In Cash
1147000
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.09804848463006074
Annuals > 1 > ratios > PB
0.37008779680692805
Annuals > 1 > ratios > ROE
-10.551482307937519
Annuals > 1 > ratios > ROA
-8.07382714041792
Annuals > 1 > ratios > FCF
1943000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.1108891679032074
Annuals > 1 > health Score
44
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
23525000
Annuals > 2 > income Statement > cost Of Revenue
10343000
Annuals > 2 > income Statement > gross Profit
13182000
Annuals > 2 > income Statement > operating Expenses
12653000
Annuals > 2 > income Statement > operating Income
529000
Annuals > 2 > income Statement > interest Expense
158000
Annuals > 2 > income Statement > pretax Income
404000
Annuals > 2 > income Statement > net Income
862000
Annuals > 2 > income Statement > eps
0.04104726330467041
Annuals > 2 > income Statement > dividends Per Share
6000
Annuals > 2 > income Statement > shares Outstanding
21000182
Annuals > 2 > income Statement > income Tax Expense
-458000
Annuals > 2 > income Statement > EBITDA
2000000
Annuals > 2 > income Statement > operating Margin
2.2486716259298616
Annuals > 2 > income Statement > total Other Income Expense Net
-125000
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
8238000
Annuals > 2 > balance Sheet > short Term Investments
72000
Annuals > 2 > balance Sheet > receivables
6239000
Annuals > 2 > balance Sheet > inventories
5646000
Annuals > 2 > balance Sheet > total Current Assets
20516000
Annuals > 2 > balance Sheet > property Plant Equipment
2308000
Annuals > 2 > balance Sheet > total Assets
28484000
Annuals > 2 > balance Sheet > payables
5591000
Annuals > 2 > balance Sheet > short Term Debt
405000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7388000
Annuals > 2 > balance Sheet > equity
21096000
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
862000
Annuals > 2 > cash Flow > depreciation
1471000
Annuals > 2 > cash Flow > change In Working Capital
-3715000
Annuals > 2 > cash Flow > cash From Operations
-1020000
Annuals > 2 > cash Flow > capital Expenditures
229000
Annuals > 2 > cash Flow > cash From Investing
-290000
Annuals > 2 > cash Flow > cash From Financing
-1846000
Annuals > 2 > cash Flow > net Change In Cash
-3093000
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
0.04104726330467041
Annuals > 2 > ratios > PB
0.3423380067216534
Annuals > 2 > ratios > ROE
4.086082669700417
Annuals > 2 > ratios > ROA
3.026260356691476
Annuals > 2 > ratios > FCF
-1249000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.05309245483528161
Annuals > 2 > health Score
54
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
16769000
Annuals > 3 > income Statement > cost Of Revenue
6755000
Annuals > 3 > income Statement > gross Profit
10014000
Annuals > 3 > income Statement > operating Expenses
10733000
Annuals > 3 > income Statement > operating Income
-719000
Annuals > 3 > income Statement > interest Expense
236000
Annuals > 3 > income Statement > pretax Income
-1009000
Annuals > 3 > income Statement > net Income
-1105000
Annuals > 3 > income Statement > eps
-0.053239439198392316
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
20755290
Annuals > 3 > income Statement > income Tax Expense
96000
Annuals > 3 > income Statement > EBITDA
606000
Annuals > 3 > income Statement > operating Margin
-4.287673683582802
Annuals > 3 > income Statement > total Other Income Expense Net
-290000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
11331000
Annuals > 3 > balance Sheet > short Term Investments
79000
Annuals > 3 > balance Sheet > receivables
3747000
Annuals > 3 > balance Sheet > inventories
4392000
Annuals > 3 > balance Sheet > total Current Assets
20092000
Annuals > 3 > balance Sheet > property Plant Equipment
2576000
Annuals > 3 > balance Sheet > total Assets
28923000
Annuals > 3 > balance Sheet > payables
5327000
Annuals > 3 > balance Sheet > short Term Debt
1343000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8397000
Annuals > 3 > balance Sheet > equity
20526000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1105000
Annuals > 3 > cash Flow > depreciation
1379000
Annuals > 3 > cash Flow > change In Working Capital
-1466000
Annuals > 3 > cash Flow > cash From Operations
-1597000
Annuals > 3 > cash Flow > capital Expenditures
346000
Annuals > 3 > cash Flow > cash From Investing
-846000
Annuals > 3 > cash Flow > cash From Financing
-500000
Annuals > 3 > cash Flow > net Change In Cash
-2950000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.053239439198392316
Annuals > 3 > ratios > PB
0.3477416072785735
Annuals > 3 > ratios > ROE
-5.383416155120335
Annuals > 3 > ratios > ROA
-3.8204888842789475
Annuals > 3 > ratios > FCF
-1943000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.11586856699862842
Annuals > 3 > health Score
34
Valuation > metrics > PE
34.389
Valuation > metrics > PB
0.39411465636687987
Valuation > final Score
58.7332
Valuation > verdict
11.5% Undervalued
Profitability > metrics > ROE
4.632135826771654
Profitability > metrics > ROA
4.710666249609009
Profitability > metrics > Net Margin
0.13962544038568514
Profitability > final Score
44
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3198818897637795
Risk > metrics > Interest Coverage
-16.2
Risk > final Score
-5
Risk > verdict
High
Liquidity > metrics > Current Ratio
33.02685950413223
Liquidity > metrics > Quick Ratio
21.946280991735538
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
45
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
100
Prev Risks > 1
-294
Prev Risks > 2
-11
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:39:31.874Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.029
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0303
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0341
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-11
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0061
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0394
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0348
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0237
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-13
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0055
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-08
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0469
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0103
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0099
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-15
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.042
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0071
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0014
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-11
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0179
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-23
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.0336
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-11
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0344
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-30
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0342
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0342
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-30
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0279
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0279
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0168
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0168
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0252
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0252
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0.1427
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.1427
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.1105
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.1105
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.017
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.017
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0179
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0179
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0.0032
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0032
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0.0758
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0758
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
0.0015
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.0015
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
0.1085
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0.1085
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.0136
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.0136
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.023
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.023
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-31
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0209
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0209
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-12-31
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.4663
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.4663
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-09-30
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0262
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.0262
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-06-30
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
0.0298
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0.0298
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-31
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.1689
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.1689
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-12-31
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.2808
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.2808
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-09-30
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.1484
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
-0.1484
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-06-30
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.1569
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
-0.1569
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-12-31
Earnings History > 40 > report Date
2016-03-31
Earnings History > 40 > date
2015-12-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.3382
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
-0.3382
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-09-30
Earnings History > 41 > report Date
2015-12-31
Earnings History > 41 > date
2015-09-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.1611
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
-0.1611
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-06-30
Earnings History > 42 > report Date
2015-09-30
Earnings History > 42 > date
2015-06-30
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.1534
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
-0.1534
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2015-03-31
Earnings History > 43 > report Date
2015-06-30
Earnings History > 43 > date
2015-03-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.4005
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
-0.4005
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-12-31
Earnings History > 44 > report Date
2015-03-31
Earnings History > 44 > date
2014-12-31
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.1672
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
-0.1672
Earnings History > 44 > surprise Percent
-
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud and Aquafolia brands; and medical aesthetics under the Pro-Derm and Alyria brands for non-invasive and minimally invasive procedures or skincare treatments. The company also distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; ART FILLER, a hyaluronic acid-based dermal filler; and MicronJet, an intradermal injection device. The company has commercialization license agreement with Cantabria Labs Inc.; and development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Crescita Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.029
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.